ChargePoint Technology Ltd

ChargePoint’s containment solutions provide a reduced risk of cross-contamination via closed transfers, ensure the safety of your personnel and provide a dust-free environment when processing toxic powders and high potent APIs.

The containment performance of ChargePoint’sPharmaSafe® split butterfly valves has been independently validated by customers and third parties according to the ISPE SMEPAC (Standardised Measurement of Equipment Particulate Airborne Contamination) guidelines.

The validated performance value levels of the containment provided by thePharmaSafe® valve range is up to OEB5/<0.1ug/m3.

ChargePoint’s containment solutions provide a reduced risk of cross-contamination via closed transfers, ensure the safety of your personnel and provide a dust-free environment when processing toxic powders and high potent APIs.

OurPharmaSafe® containment solutions can also maximize the yield of poorly flowing, high-value products whilst removing the requirement for high air class control areas and cumbersome PPE.

Single-use solutions

ChargePoint’s single-use solutions provide the containment and sterility assurance required for handling high potent ingredients and chemicals with the cost-effectiveness of disposable technology.

ChargeBagPE-S withHiPure™ ULP7

The single-useChargeBagis a cost-effective and convenient container for the handling, storage, and transfer of bio-pharmaceutical powders, made withHiPure™ ULP7, a new pharma-ready LLDPE film developed by ChargePoint Technology, to meet the demands of even the most critical aseptic processing environments.

A single-use transfer device that doesn’t come at the cost of containment

The ChargePoint® SUP (Single Use Passive) is a contained powder transfer interface for pharmaceutical manufacturers that need to transfer powder ingredients economically, without compromising on performance unlike many disposable options. As the Passive mating half of the ChargePoint Split Butterfly Valve system it delivers outstanding containment and sterility assurance performance whilst eliminating the cost and risks associated with cleaning, maintenance and subsequent validation.

One solution for two sites – Multi-Site Powder Handling Kits

Today, morePharmaceuticalcompanies than ever are utilizing multiple manufacturing locations. Consequently, more drug products are being moved between facilities. Assuring the integrity of these expensive, sensitive powders whilst in transit is a challenge that is currently met with common packaging solutions that while meet the needs for transportation, often give facilities a headache when it comes to filling, sealing, handling, and emptying. One method that works well for facility A, may not work so well for facility B or vice versa.

With our single-use solutions your method of contained powder transfer within facility A (drug supply), can also be used as your product primary packaging and container closure for transportation to facility B (drug product formulation). And furthermore, this package can be used as a common method of transfer into your process line in facility B with the ChargePoint® SUP containment interface combined withChargeBag.

Sterility assurance solutions

ChargePoint’s product range for sterility assurance has been developed to perform aseptic transfers that maintain critical area integrity, reduce the risk of contamination via closed transfers and meet GMP and product quality requirements.

OurAseptiSafe® product range for sterility assurance has been purposely developed to perform aseptic transfers that:

The range removes the requirement for large, high-grade control areas by maintaining the critical area with the split butterfly valve and the single-use bag system eliminates cleaning and sterilization associated with rigid containers.

All products suitable for aseptic manufacturing are independently validated by third parties according to ISPE containment performance measurement (SMEPAC) guidelines providing unrivaled, validated levels of containment performance alongside sterility assurance.